Sort
82,697 grants matching “vaccine development”
Assessment of Heterologous Prime-boost HIV Vaccine Regimen to Elicit Cross-reactive Neutralizing Antibodies Targeting HIV Fusion Peptide
$1,722,748Ronald Veazey · Tulane University Of Louisiana · N01 · FY2024 · AI
Multiscale Analysis of Immune Responses
$1,722,622Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$1,722,584Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Application of Flow Cytometry to Cell Biology
$1,722,364Susan Sharrow · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses
$1,722,037Daved Fremont · Washington University · N01 · FY2021 · AI
Translational Immunology research: a support for clinical immunological research
$1,721,044Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2023 · AR
Host Defense Against HIV-related Pulmonary Infections
$1,720,806Judd E Shellito · Lsu Health Sciences Center · P01 · FY2014 · HL
NOVEL CELLULAR AND VIRAL TARGETS FOR ANTI-INFLUENZA VIRUS DRUGS
$1,720,082Peter Palese · Icahn School Of Medicine At Mount Sinai · U01 · FY2007 · AI
Multiscale Analysis of Immune Responses
$1,720,031Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Task 17 (C31): EFFICACY TESTING OF THERAPEUTICS AGAINST ANTHRAX IN RABBITS
$1,719,970Lovelace Biomedical & Environmental Research Institute · N01 · FY2009 · AI
Production of Pedigreed SPF Rhesus Macaques
$1,719,934Nicholas W Lerche · University Of California At Davis · U42 · FY2009 · RR
The Miami Center for AIDS Research
$1,719,537Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2012 · AI
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
$1,719,534Ruth Margrit Ruprecht · University Of Louisiana At Lafayette · U19 · FY2021 · AI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$1,719,454Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
The humoral response to Zika virus infection and vaccination
$1,718,620Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Evolution & Maintenance of Memory CD8 T Cells
$1,718,593Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · AI
Recombinant Virus Vaccines
$1,717,946Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
$1,717,013Rhea N Coler · Access To Advanced Health Institute · U01 · FY2011 · AI
Preclinical Core
$1,716,552Koen K Van Rompay · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · AI
Evolution & Maintenance of Memory CD8 T Cells
$1,716,544Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2016 · AI
Evolution & Maintenance of Memory CD8 T Cells
$1,716,544Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2015 · AI
Evolution & Maintenance of Memory CD8 T Cells
$1,716,544Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2014 · AI
Rapid generation and testing of live-attenuated vaccines against SARS-CoV-2
$1,716,496Steffen Mueller · Codagenix, Inc. · R44 · FY2020 · AI
Ebola Vaccine Development
$1,716,419Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Ebola Vaccine Development
$1,716,419Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI